Patient Pathfinder: Clinical Trials
Clinical Trials for Prostate Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 811 active Prostate Cancer trials
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Study Type: Interventional Phase 2
Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate
Study Type: Interventional Phase 2
Genetic Evaluation of Men (GEM)
Study Type: Observational
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
Study Type: Observational
Abiraterone Acetate for Castrate Resistant Prostate Cancer
Study Type: Interventional
68Ga PSMA in Preprostatectomy Patients
Study Type: Interventional Phase 2
MRI Guided SBRT for Localized Prostate Cancer
Study Type: Interventional
A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation
Study Type: Interventional Phase 3
There are 811 active Prostate Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now